Manufacturing of pharmaceuticals based on human proteins derived from human cell lines and plasma. Development of treatments for hematology, immunology, and intensive care.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Octapharma's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: July 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
LFB
B
Development, manufacturing, and marketing of plasma-derived biopharmaceuticals for serious and often rare diseases in hemostasis, immunology, and intensive care.
Xenothera
B
Development of innovative immunological treatments using glyco-humanized antibodies. Conducts clinical trials and collaborates with partners in areas like oncology and xenotransplantation.
ProteoGenix
B
Production of antibodies, recombinant protein expression and purification, peptide synthesis, and gene synthesis for research and therapeutic development.
Initiatives identified among leaders
Réduction des accidents, formations, mobilité interne et diversité des talents
“Le groupe met en place des actions pour garantir u...” - LFBÉvénements et enquête pour stagiaires et alternants en France
“LFB organise des événements internes appelés « Sha...” - LFBRéduction des émissions liées aux livraisons par ouverture d'une filiale américaine
“L'ouverture d'une filiale aux États-Unis permet d'...” - ProteoGenix76% of similar organizations communicate on CSR issues
+955 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports